REQUEST A DEMO
Total
USD $0.00
Search more companies

Institut Za Virusologiju, Vakcine I Serume torlak (Serbia)

Main Activities: Outpatient Care Centers
Full name: Institut Za Virusologiju, Vakcine I Serume torlak Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Institut Za Virusologiju, Vakcine I Serume torlak is based in Serbia. The head office is in Belgrade. It operates in the Outpatient Care Centers sector. The company was established on July 10, 1995. 227 (2019) employees currently work for Institut Za Virusologiju, Vakcine I Serume torlak. From the latest financial highlights, Institut Za Virusologiju, Vakcine I Serume torlak reported a net sales revenue drop of 51.76% in 2022. Its’ total assets recorded a negative growth of 17.13%. The net profit margin of Institut Za Virusologiju, Vakcine I Serume torlak decreased by 8.15% in 2022.

Headquarters
Vojvode Stepe 458
Belgrade; Belgrade; Postal Code: www.torlak.rs

Contact Details: Purchase the Institut Za Virusologiju, Vakcine I Serume torlak report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Institut Za Virusologiju, Vakcine I Serume torlak report to view the information.
Outstanding Shares:
Purchase the Institut Za Virusologiju, Vakcine I Serume torlak report to view the information.
Registered Capital:
Purchase the Institut Za Virusologiju, Vakcine I Serume torlak report to view the information.
Incorporation Date:
July 10, 1995
Key Executives
Purchase this report to view the information.
Acting Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Biomedicinski Centar Instituta Torlak D.O.O.Beograd - U Likvidaciji
100%
Company Performance
Financial values in the chart are available after Institut Za Virusologiju, Vakcine I Serume torlak report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-51.76%
Total operating revenue
-61.5%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-95.98%
Total assets
-17.13%
Total equity
0.64%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-8.15%
Return on Equity (ROE)
-15.27%
Quick Ratio
0.68%
Cash Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?